| Primary |
| Constipation |
33.3% |
| Hypertension |
33.3% |
| Arrhythmia |
16.7% |
| Asthma |
16.7% |
|
|
| Secondary |
| Drug Use For Unknown Indication |
43.9% |
| Product Used For Unknown Indication |
19.0% |
| Acute Myeloid Leukaemia |
3.3% |
| Hypertension |
3.3% |
| Cholelithiasis |
3.1% |
| Constipation |
3.0% |
| Depression |
3.0% |
| Cholecystectomy |
2.7% |
| Colon Cancer |
2.7% |
| Influenza |
2.7% |
| Pain |
2.2% |
| Pyelonephritis |
1.6% |
| Type 2 Diabetes Mellitus |
1.5% |
| Arrhythmia |
1.4% |
| Haemorrhoids |
1.4% |
| Insomnia |
1.4% |
| Atrial Fibrillation |
1.1% |
| Chemotherapy |
1.1% |
| Ill-defined Disorder |
1.1% |
| Chronic Obstructive Pulmonary Disease |
0.8% |
|
| Hyponatraemia |
10.3% |
| Eczema |
8.4% |
| Death |
7.5% |
| Interstitial Lung Disease |
6.5% |
| Renal Failure Acute |
6.5% |
| Neutropenia |
5.6% |
| Pancreatitis Acute |
5.6% |
| Pruritus Generalised |
4.7% |
| Rash Maculo-papular |
4.7% |
| Stevens-johnson Syndrome |
4.7% |
| Thrombocytopenia |
4.7% |
| Vomiting |
4.7% |
| Gait Disturbance |
3.7% |
| Pyrexia |
3.7% |
| Respiratory Disorder |
3.7% |
| Urinary Incontinence |
3.7% |
| Eosinophilia |
2.8% |
| Hyperhidrosis |
2.8% |
| Night Sweats |
2.8% |
| Pregnancy With Contraceptive Device |
2.8% |
|
| Concomitant |
| Drug Use For Unknown Indication |
35.3% |
| Product Used For Unknown Indication |
18.7% |
| Pain |
6.3% |
| Constipation |
6.0% |
| Hypertension |
5.2% |
| Prophylaxis |
3.6% |
| Depression |
2.6% |
| Anxiety |
2.6% |
| Back Pain |
2.5% |
| Multiple Myeloma |
2.1% |
| Sarcoma Metastatic |
1.8% |
| Atrial Fibrillation |
1.7% |
| Nausea |
1.7% |
| Epilepsy |
1.6% |
| Thrombosis Prophylaxis |
1.6% |
| Insomnia |
1.5% |
| Rheumatoid Arthritis |
1.4% |
| Unevaluable Event |
1.4% |
| Parkinson's Disease |
1.3% |
| Diabetes Mellitus |
1.2% |
|
| Vomiting |
10.3% |
| Thrombocytopenia |
10.1% |
| Renal Failure Acute |
9.1% |
| Renal Failure |
7.0% |
| Somnolence |
5.8% |
| Weight Decreased |
5.3% |
| Fall |
5.1% |
| Hyponatraemia |
4.7% |
| Pyrexia |
4.7% |
| Pulmonary Embolism |
4.5% |
| Sepsis |
3.9% |
| Urinary Retention |
3.9% |
| Toxic Skin Eruption |
3.7% |
| Cytolytic Hepatitis |
3.5% |
| General Physical Health Deterioration |
3.3% |
| Neutropenia |
3.3% |
| Malaise |
3.1% |
| Agranulocytosis |
2.9% |
| International Normalised Ratio Increased |
2.9% |
| Rhabdomyolysis |
2.9% |
|
